Exosurf Versus Survanta Surfactant Preparations: Proportional-Hazards Regression Analysis of Time to Successful Extubation and Discontinuation of Oxygen Therapy

Journal of Perinatology

Volumn 16, Issue 1, 1996, Pages 9-14

  Arnold, Cody ^a,b   Adams, Elaine ^a   Torres, Evelyn ^a   Sidebottom, Richard ^a  

^a Harris Methodist Fort Worth Hospital   (United States)

^b Cook Ft Worth Children's Med Ctr ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BERACTANT; BIOLOGICAL PRODUCT; DIPALMITOYLPHOSPHATIDYLCHOLINE; FATTY ALCOHOL; LUNG SURFACTANT; MACROGOL DERIVATIVE; OXYGEN; PHOSPHORYLCHOLINE;

AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COMBINATION; FEMALE; HUMAN; HYALINE MEMBRANE DISEASE; INTUBATION; MALE; MULTICENTER STUDY; NEWBORN; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; SURVIVAL; TIME;

AGED; BIOLOGICAL PRODUCTS; DRUG COMBINATIONS; FATTY ALCOHOLS; FEMALE; HUMANS; HYALINE MEMBRANE DISEASE; INFANT, NEWBORN; INTUBATION; MALE; OXYGEN; PHOSPHORYLCHOLINE; POLYETHYLENE GLYCOLS; PROPORTIONAL HAZARDS MODELS; PULMONARY SURFACTANTS; REGRESSION ANALYSIS; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 0029678629     PISSN: 07438346     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Soll R, McQueen M. Respiratory distress syndrome. In: Sinclair J, Bracken M, eds. Effective care of the newborn infant. Oxford: Oxford University Press, 1992:329-49.
2. Harris H, Albert A. Survivorship analysis for clinical studies. New York: Marcel Dekker, 1991.
3. Lee E. Statistical methods for survival data analysis. 2nd ed. New York: John Wiley & Sons, 1992.
4. Selvin S. Statistical analysis of epidemiologic data. New York: Oxford University Press, 1991.
5. Steinberg D, Colla P. Survival: a supplementary module for SYSTAT. Evanston, Illinois: SYSTAT, Inc., 1988.
6. Rothman K, Modern epidemiology. Boston: Little, Brown, 1986:125-6.
7. Naeye R, Tafari N. Risk factors in pregnancy and disease of the fetus and newborn. Baltimore: Williams and Wilkins, 1983:317, 320.
8. Phelps D, Brown B, Cassady G, et al. 28-Day survival rates of 6676 neonates with birth weight of 1250 grams or less. Pediatrics 1991;87: 7-17.
9. Horbar J, Wright E, Onstad L. Decreasing mortality with the introduction of surfactant therapy: an observational study of neonates weighing 601 to 1300 grams at birth. Pediatrics 1993;92:191-6.
10. Epilog plus: statistical package for epidemiology and clinical trials. Pasadena, California: Epicenter software, 1991.
11. Horbar J, Wright L, Soll R, et al. A multicenter randomized trial comparing two surfactants for the treatment of neonatal respiratory distress syndrome. J Pediatr 1993;123:757-66.
12. Alvarado M, Hingre R, Hakanson D, Gross S. Clinical trial of Survanta vs Exosurf therapy in infants < 1500 g with respiratory distress syndrome [Abstract 1865]. Pediatr Res 1993;33:216A.
13. Job L, Nystrom G, Demming D. Better response to modified natural surfactant than to synthetic surfactant: real difference or "learning curve" [Abstract 1278]. Pediatr Res 1993;33:216A.
14. Pearlman S, Leef K, Stefano J, Spear M, Esterly K. A randomized trial comparing Exosurf vs. Survanta in the treatment of neonatal RDS [Abstract 2017]. Pediatr Res 1993;33:340A.
15. Wei T, Sun S. Outcome difference in surfactant replacement therapy: Exosurf vs Survanta [Absrract 1438]. Pediatr Res 1993;33:243A.